38 research outputs found
The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
Purpose - We wanted to examine the potential of the Scandinavian Sarcoma Group (SSG) Central Register, and evaluate referral and treatment practice for soft-tissue sarcomas in the extremities and trunk wall (STS) in the Nordic countries. Background - Based on incidence rates from the literature, 8,150 (7,000-9,300) cases of STS of the extremity and trunk wall should have been diagnosed in Norway, Finland, Iceland, and Sweden from 1987 through 2011. The SSG Register has 6,027 cases registered from this period, with 5,837 having complete registration of key variables. 10 centers have been reporting to the Register. The 5 centers that consistently report treat approximately 90% of the cases in their respective regions. The remaining centers have reported all the patients who were treated during certain time periods, but not for the entire 25-year period. Results - 59% of patients were referred to a sarcoma center untouched, i.e. before any attempt at open biopsy. There was an improvement from 52% during the first 5 years to 70% during the last 5 years. 50% had wide or better margins at surgery. Wide margins are now achieved less often than 20 years ago, in parallel with an increase in the use of radiotherapy. For the centers that consistently report, 97% of surviving patients are followed for more than 4 years. Metastasis-free survival (MFS) increased from 67% to 73% during the 25-year period. Interpretation - The Register is considered to be representative of extremity and trunk wall sarcoma disease in the population of Scandinavia, treated at the reporting centers. There were no clinically significant differences in treatment results at these centers.Peer reviewe
Measurement of global polarization of {\Lambda} hyperons in few-GeV heavy-ion collisions
The global polarization of {\Lambda} hyperons along the total orbital angular
momentum of a relativistic heavy-ion collision is presented based on the high
statistics data samples collected in Au+Au collisions at \sqrt{s_{NN}} = 2.4
GeV and Ag+Ag at 2.55 GeV with the High-Acceptance Di-Electron Spectrometer
(HADES) at GSI, Darmstadt. This is the first measurement below the strangeness
production threshold in nucleon-nucleon collisions. Results are reported as a
function of the collision centrality as well as a function of the hyperon
transverse momentum (p_T) and rapidity (y_{CM}) for the range of centrality
0--40%. We observe a strong centrality dependence of the polarization with an
increasing signal towards peripheral collisions. For mid-central (20--40%)
collisions the polarization magnitudes are (%) = 6.0 \pm 1.3
(stat.) \pm 2.0 (syst.) for Au+Au and (%) = 4.6 \pm 0.4 (stat.)
\pm 0.5 (syst.) for Ag+Ag, which are the largest values observed so far. This
observation thus provides a continuation of the increasing trend previously
observed by STAR and contrasts expectations from recent theoretical
calculations predicting a maximum in the region of collision energies about 3
GeV. The observed polarization is of a similar magnitude as predicted by 3D
fluid dynamics and the UrQMD plus thermal vorticity model and significantly
above results from the AMPT model.Comment: 8 pages, 4 figure
Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.
PURPOSE: Histologic grade is currently the best predictor of clinical course in chondrosarcoma patients. Grading suffers, however, from extensive interobserver variability and new objective markers are needed. Hence, we have investigated DNA copy numbers in chondrosarcomas with the purpose of identifying markers useful for prognosis and subclassification. EXPERIMENTAL DESIGN: The overall pattern of genomic imbalances was assessed in a series of 67 chondrosarcomas using array comparative genomic hybridization. Statistical analyses were applied to evaluate the significance of alterations detected in subgroups based on clinical data, morphology, grade, tumor size, and karyotypic features. Also, the global gene expression profiles were obtained in a subset of the tumors. RESULTS: Genomic imbalances, in most tumors affecting large regions of the genome, were found in 90% of the cases. Several apparently distinctive aberrations affecting conventional central and peripheral tumors, respectively, were identified. Although rare, recurrent amplifications were found at 8q24.21-q24.22 and 11q22.1-q22.3, and homozygous deletions of loci previously implicated in chondrosarcoma development affected the CDKN2A, EXT1, and EXT2 genes. The chromosomal imbalances in two distinct groups of predominantly near-haploid and near-triploid tumors, respectively, support the notion that polyploidization of an initially hyperhaploid/hypodiploid cell population is a common mechanism of chondrosarcoma progression. Increasing patient age as well as tumor grade were associated with adverse outcome, but no copy number imbalance affected metastasis development or tumor-associated death. CONCLUSION: Despite similarities in the overall genomic patterns, the present findings suggest that some regions are specifically altered in conventional central and peripheral tumors, respectively